What the Radiograph Cannot Promise: The Snapshot and the Verdict

The radiographs arrive before the conversation does. A set of images -- navicular bones, hocks, stifles, sometimes the cervical spine -- uploaded to a shared folder or texted in a series of high-resolution files. The buyer opens them on a laptop in a barn office or at a kitchen table a thousand miles from the horse, scrolling through views of anatomy that will determine whether a five- or six-figure wire transfer goes through. Everything now hinges on what the veterinarian sees, what they say, and how the buyer hears it.

This is the pre-purchase examination -- the PPE, or, in British parlance, the vetting. It is the single most consequential veterinary interaction in the sport horse market, and it was never designed for the weight it now carries.

More Than Half

A 2025 study from the Royal Veterinary College in London examined 133 pre-purchase examination certificates from three first-opinion equine practices across the United Kingdom. The finding was striking: 57.1 percent of the horses examined had at least one finding considered prejudicial to the horse's suitability for its intended use.

Lameness accounted for the majority of those findings, at 55.3 percent. Diagnostic imaging abnormalities followed at 14.5 percent. Respiratory, dermatological, and cardiac findings made up the remainder. And the study revealed a quiet irony: horses with higher purchase prices were more likely to undergo the more thorough five-stage vetting, more likely to have radiographs taken, and -- as a direct consequence -- more likely to have prejudicial findings identified. The more you spend, the more you look. The more you look, the more you find.

The Same Bone, Read Differently

If the finding rate were the only issue, the solution would be straightforward: better diagnostics, clearer thresholds, more data. But a separate study -- also published in the Equine Veterinary Journal in 2025 -- exposed a deeper structural problem. When 211 equine veterinarians from around the world were presented with the same four sets of radiographic images -- navicular bones, tarsi, and stifles representing normal, mild, moderate, and marked pathological change -- their assessments varied substantially.

As expected, concern rose with the severity of the pathology. But the range of responses was wide at every grade. A navicular bone that one veterinarian graded at minimal concern, another read as a serious red flag. The same stifle image that prompted one clinician to recommend purchase prompted another to advise against it. Neither was necessarily wrong. They were exercising clinical judgment -- but in a system that treats their opinion as a verdict, that variability matters enormously.

A horse that passes with one veterinarian may fail with another -- not because the anatomy changed, but because the reader did.

The Expanding Frame

The scope of the pre-purchase radiographic workup has grown steadily. Where a standard set once covered the feet, hocks, and stifles, many buyers -- and their agents -- now request cervical spine films, thoracolumbar views, and comprehensive fetlock series. Each additional view adds cost and information, but not always clarity.

A 2024 review published in Equine Veterinary Education found that most findings on cervical radiographs of clinically normal horses are of unknown or low clinical significance. Morphological variations of the vertebrae, mild osteoarthritis, and osteochondral fragmentation are commonly present in horses showing no symptoms whatsoever. The same journal published a related review asking whether thoracolumbar spine radiographs should remain a standard part of the examination at all.

More recently, a 2026 study in the Equine Veterinary Journal reviewed 673 fetlock radiographic series and found that a reduced protocol -- just two views rather than a full series -- detected most pathologies as effectively as the comprehensive set. The implication is not that radiographs are unnecessary, but that adding more images does not reliably produce better decisions. At some point, the radiograph reveals anatomy. What it cannot reveal is the future.

The Shadow of Litigation

Behind every pre-purchase examination sits a legal reality that shapes the process in ways most buyers never see. According to the AVMA Professional Liability Insurance Trust, pre-purchase examination disputes are the single most common source of equine veterinary malpractice claims in the United States. The most frequently cited cause: missed radiographic lesions.

Equine-specific claims account for roughly five percent of the Trust's annual caseload of 3,500 to 4,000 notices -- but they produce disproportionately high payouts, a function of the animals' value. A sport horse purchased for six figures and found to be unsound six months later generates a dispute that scales with the price tag, not the complexity of the diagnosis.

The result is a quiet feedback loop. Litigation makes veterinarians more conservative. Conservative readings flag more findings. More findings kill more deals. Failed deals generate frustration, and frustration -- when enough money is involved -- generates more litigation. The veterinarian operating in this environment is no longer simply evaluating a horse. They are managing their own liability, and the buyer's expectations, and the seller's disclosure, and the agent's pressure, all at once.

A Different Framework

At the 2026 National Equine Forum in London, a panel chaired by David Mountford -- chief executive of the British Equine Veterinary Association -- convened to examine where the pre-purchase examination process is failing. The panel included equine clinicians Dr Mark Georgetti, Dr Lucy Grieve, and Dr Sam Cutts, alongside professional seller Julia Martin.

Their central recommendation was structural: move away from the binary pass/fail model and toward a risk-based assessment framework. Acknowledge variability. Improve transparency in veterinary histories so that horses carry a continuous medical record rather than presenting as blank slates at each sale. Foster collaboration between veterinarians, farriers, and physiotherapists so that the PPE draws on a broader clinical picture. And recalibrate buyer expectations -- not to lower the bar, but to relocate it from certainty to informed judgment.

The panel identified a paradox familiar to anyone who has bought a sport horse: the market rewards opacity. A horse with no veterinary history on file appears clean. A horse with years of documented care -- routine maintenance, minor joint injections, a resolved soft-tissue issue -- carries a paper trail that reads as risk. The horse with records is often the better-maintained animal. But in a pass/fail system, documentation becomes a liability.

A system that penalizes transparency does not incentivize it. And a market that lacks transparency does not serve anyone well -- least of all the horse.

What the Buyer Can Do

The pre-purchase examination is not broken. But it is misunderstood -- by buyers who want certainty from an instrument that offers probability, and by a market structure that treats a clinical snapshot as a final word. The research does not argue for fewer radiographs or less scrutiny. It argues for better interpretation, clearer communication, and a framework that distinguishes between a finding and a problem.

Use your own veterinarian, not the seller's. Ask for a risk-based assessment rather than a pass/fail opinion. Discuss findings in the context of the horse's intended use and level of work, not in the abstract. Request the seller's veterinary history -- and understand that a horse with records is not a horse with problems. Recognize that two skilled veterinarians can look at the same radiograph and reach different conclusions, and that this is not a failure of the system but a feature of clinical medicine.

The vetting cannot promise what happens next. No examination can. What it offers, at its best, is a clear-eyed view of what is there right now -- and a conversation worth having before the wire goes through.